(Q24236654)

1

0 references

G V Asokan

2

0 references

Jai Shanthini Singaram

4

0 references

Tim WR Lee

Cochrane Database of Systematic Reviews

5

0 references

publication date

17 March 2010

0 references

published in

0 references

cites work

Severe viral respiratory infections in infants with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

Acute severe deterioration in cystic fibrosis associated with influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

Vaccines for preventing influenza in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

Vaccines for preventing influenza in people with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

Neuraminidase inhibitors for preventing and treating influenza in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

Neuraminidase inhibitors for preventing and treating influenza in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

Neuraminidase inhibitors for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

Oseltamivir for treatment and prophylaxis of influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

Is there a role for influenza vaccination in cystic fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008139.PUB2